financetom
Business
financetom
/
Business
/
SEBI introduces mechanism of net settlement of cash, Futures and Options segment upon expiry
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SEBI introduces mechanism of net settlement of cash, Futures and Options segment upon expiry
Nov 30, 2022 2:01 PM

Securities and Exchange Board of India (SEBI) on Wednesday introduced the mechanism of net settlement of cash and Futures and Options (F&O) segment upon expiry of stock derivatives. The move is aimed at providing better alignment of cash and derivatives segment, mitigation of price risk in certain cases and netting efficiencies for market participants, the Capital markets regulator SEBI said in a circular.

Share Market Live

NSE

Under the mechanism, the obligations arising out of cash segment settlement and physical settlement of F&O segments, upon expiry of stock derivatives, would be settled on a net basis as against the current approach of settling such obligations separately.

The benefit of netting (merged settlements) would be available to investors who trade and clear through the same TM-CM (trading member-clearing member) combination in cash and F&O segment.

Also Read: SEBI reduces timeline for listing of debt securities issued on private placement basis

However, investors whose TM clears trades through different CM/Clearing Corporation (CC) will not be able to avail the benefit of netting.

SEBI said that netting of settlement obligations of cash segment and physical settlement of F&O segment would not be available for the institutional investors including Foreign Portfolio Investors as the regulatory framework specifies that all transactions by the institutional investors in the cash market should be backed by delivery.

Further, netting of delivery obligations would be only for the purpose of settlement. Therefore, Securities Transaction Tax (STT) and Stamp Duty would continue to be computed, levied and reported segment-wise.

The new guideline would come into force from March 2023 expiry of F&O contract. In September, the board of SEBIB approved a proposal in this regard.

Also Read: SEBI issues operational guidelines on 'scheme of arrangement' for entities with listed debt securities

(Edited by : Anushka Sharma)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why AEON Biopharma Stock Is Down 65% Today
Why AEON Biopharma Stock Is Down 65% Today
Jan 6, 2025
AEON Biopharma Inc ( AEON ) shares are trading lower by 65% to 19 cents during Monday’s session after the company announced the pricing of a $20 million offering of 40 million units at 50 cents per unit. The funds will support AEON's development of ABP-450, a biosimilar to BOTOX for therapeutic use and enable comparative studies under the 351(k) pathway. CEO Marc Forth...
OSI Systems Secures $27 Million Order for Screening Solutions
OSI Systems Secures $27 Million Order for Screening Solutions
Jan 6, 2025
11:23 AM EST, 01/06/2025 (MT Newswires) -- OSI Systems ( OSIS ) said Monday that its security division received an order for about $27 million from an international customer for checkpoint and hold baggage screening products. The order includes Real Time Tomography 110 explosive detection system, Orion 920 Computed Tomography checkpoint screening system integrated with Rapiscan tray return system, Orion...
Cryoport Unit MVE Registers Manufacturing Facilities With FDA
Cryoport Unit MVE Registers Manufacturing Facilities With FDA
Jan 6, 2025
11:15 AM EST, 01/06/2025 (MT Newswires) -- Cryoport ( CYRX ) said Monday that its MVE Biological Solutions unit has registered its three manufacturing facilities with the US Food and Drug Administration. The company said that all applicable cryogenic freezers and dewars manufactured by MVE are now listed with the FDA. Cryoport ( CYRX ) shares were up 1.4% in...
Ingredion Stops Operations at Manufacturing Facility in Vanscoy, Canada
Ingredion Stops Operations at Manufacturing Facility in Vanscoy, Canada
Jan 6, 2025
11:19 AM EST, 01/06/2025 (MT Newswires) -- Ingredion ( INGR ) said Monday it has stopped operations at its plant protein manufacturing facility in Vanscoy, Canada, affecting about 20 employees. The company said it intends to sell the facility and the property, though it has yet to enter into a sale agreement. Ingredion ( INGR ) expects to book about...
Copyright 2023-2026 - www.financetom.com All Rights Reserved